Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinical Trials Optional
The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider a single source application for the award of a Cooperative Agreement to the Duke Universitys Duke Clinical Research Institute (DCRI) to support the Clinical Trials Transformation Initiative (CTTI).
Award Range
Not specified - $7,500,000
Total Program Funding
$7,500,000
Number of Awards
1
Matching Requirement
No
Eligible Applicants
Additional Requirements
Duke University
Geographic Eligibility
All
Application Opens
May 1, 2024
Application Closes
July 3, 2024
Grantor
HHS-FDA (Food and Drug Administration)
Subscribe to view contact details